IAG Appoints Jason Attanucci as Chief Commercial Officer
Attanucci brings a demonstrated track record of driving innovation and growth across the life sciences industry to the clinical research imaging and company
London, UK – [January 15, 2024] — Image Analysis Group (IAG), a leading imaging Clinical Research Organization (iCRO), today announced the appointment of Jason Attanucci as its new Chief Commercial Officer, where he will lead the company’s commercial strategy, focusing on strengthening client relationships, driving revenue growth, and expanding IAG’s market presence globally.
“We are thrilled to welcome Jason to our leadership team,” said Roughan Sheedy, CEO of IAG. “With his proven track record of success in business development and deep understanding of the life sciences industry, Jason will play a pivotal role in driving our growth and delivering innovative imaging and AI-driven insights to our clients.”
“It’s an exciting time to join IAG,” said Jason. “Medical imaging plays a crucial role in pharmaceutical development, and I am eager to increase awareness about IAG’s use of innovative technology and imaging endpoints to efficiently bring treatments to market and ultimately improve patient outcomes.”
Jason brings nearly 30 years of proven leadership in life sciences and technology to IAG. Most recently, he served as Vice President and General Manager of Life Sciences at Deep 6 AI, a provider of patient recruitment and real-world data platforms. His impressive career also includes roles such as Global Head of Customer Solutions and Senior Director of Sales and Partnerships at BioFortis, a clinical research technology solutions provider. Additionally, Jason has held influential global and national leadership positions at Bioclinica, Medidata Solutions, and GenoLogics Life Sciences Software Inc., demonstrating his consistent track record of driving innovation and growth across the life sciences industry.
Jason holds degrees. in both microbiology and molecular biology from the University of Pittsburgh and studied Immunology at the University of Pittsburgh School of Medicine.
About Image Analysis Group (IAG)
IAG is a leading imaging Clinical Research Organization (iCRO) that combines medical and operational expertise with cutting-edge proprietary technologies to more efficiently advance drug development and to deliver the potential for companion diagnostic tools. IAG has been serving biotech and pharma clients globally since 2007, reliably supporting all aspects of phase I to IV imaging trials across multiple indications. With a pioneering proven innovation strategy, we enhance the value and market potential of novel therapeutic assets, as demonstrated through successful pharmaceutical partnerships.
Reach out: imaging.experts@ia-grp.com
Contact: Brittany Kearns
Phone: 571-271-7211
Email: brittany@crossroadsb2b.com